BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25429521)

  • 21. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Fauchier L; Villejoubert O; Clementy N; Bernard A; Pierre B; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Am J Med; 2016 Dec; 129(12):1278-1287. PubMed ID: 27476087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
    Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
    Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
    J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
    Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.
    Pastori D; Menichelli D; Del Sole F; Pignatelli P; Violi F;
    Mayo Clin Proc; 2021 Mar; 96(3):658-665. PubMed ID: 33308867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
    Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO-AF study.
    Pastori D; Menichelli D; Bucci T; Violi F; Pignatelli P;
    Int J Cancer; 2020 Dec; 147(12):3424-3430. PubMed ID: 32588421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial Fibrillation and Cardiovascular Outcomes in the Elderly.
    O'Neal WT; Salahuddin T; Broughton ST; Soliman EZ
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):907-13. PubMed ID: 27333877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Simon D; Steinberg BA; Hong SJ; Kowey PR; Reiffel JA; Naccarelli GV; Chang P; Gersh BJ; Peterson ED; Piccini JP;
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation.
    Ghanbari H; Başer K; Jongnarangsin K; Chugh A; Nallamothu BK; Gillespie BW; Başer HD; Suwanagool A; Crawford T; Latchamsetty R; Good E; Pelosi F; Bogun F; Morady F; Oral H
    Heart Rhythm; 2014 Sep; 11(9):1503-11. PubMed ID: 24813379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Oct; 221():789-93. PubMed ID: 27428322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Nordio F; Corbalán R; Dalby A; Dorobantu M; Mercuri M; Lanz H; Rutman H; Wiviott SD; Antman EM; Giugliano RP
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
    Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
    J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.